Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5285655
Max Phase: Preclinical
Molecular Formula: C29H38O7
Molecular Weight: 498.62
Associated Items:
ID: ALA5285655
Max Phase: Preclinical
Molecular Formula: C29H38O7
Molecular Weight: 498.62
Associated Items:
Canonical SMILES: CC(C)=CCC[C@@]1(C)CC=C(COC(=O)CCC(=O)O)c2oc(C)cc2[C@@H]1/C=C/OC(=O)C=C(C)C
Standard InChI: InChI=1S/C29H38O7/c1-19(2)8-7-13-29(6)14-11-22(18-35-26(32)10-9-25(30)31)28-23(17-21(5)36-28)24(29)12-15-34-27(33)16-20(3)4/h8,11-12,15-17,24H,7,9-10,13-14,18H2,1-6H3,(H,30,31)/b15-12+/t24-,29-/m0/s1
Standard InChI Key: RFOZWSQGWRHUBD-WCJYFFLOSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 498.62 | Molecular Weight (Monoisotopic): 498.2618 | AlogP: 6.64 | #Rotatable Bonds: 11 |
Polar Surface Area: 103.04 | Molecular Species: ACID | HBA: 6 | HBD: 1 |
#RO5 Violations: 1 | HBA (Lipinski): 7 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 4.12 | CX Basic pKa: | CX LogP: 5.75 | CX LogD: 2.67 |
Aromatic Rings: 1 | Heavy Atoms: 36 | QED Weighted: 0.16 | Np Likeness Score: 1.95 |
1. Li M, She X, Ou Y, Liu J, Yuan Z, Zhao QS.. (2022) Design, synthesis and biological evaluation of a new class of Hsp90 inhibitors vibsanin C derivatives., 244 [PMID:36274275] [10.1016/j.ejmech.2022.114844] |
Source(1):